U.S. flag

An official website of the United States government

NM_000551.4(VHL):c.330_331delinsTT (p.Ser111Cys) AND multiple conditions

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Oct 22, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002651638.4

Allele description [Variation Report for NM_000551.4(VHL):c.330_331delinsTT (p.Ser111Cys)]

NM_000551.4(VHL):c.330_331delinsTT (p.Ser111Cys)

Gene:
VHL:von Hippel-Lindau tumor suppressor [Gene - OMIM - HGNC]
Variant type:
Indel
Cytogenetic location:
3p25.3
Genomic location:
Preferred name:
NM_000551.4(VHL):c.330_331delinsTT (p.Ser111Cys)
HGVS:
  • NC_000003.12:g.10142177_10142178delinsTT
  • NG_008212.3:g.5543_5544delinsTT
  • NM_000551.4:c.330_331delinsTTMANE SELECT
  • NM_001354723.2:c.330_331delinsTT
  • NM_198156.3:c.330_331delinsTT
  • NP_000542.1:p.Ser111Cys
  • NP_000542.1:p.Ser111Cys
  • NP_001341652.1:p.Ser111Cys
  • NP_937799.1:p.Ser111Cys
  • LRG_322t1:c.330_331delCAinsTT
  • LRG_322:g.5543_5544delinsTT
  • LRG_322p1:p.Ser111Cys
  • NC_000003.11:g.10183861_10183862delinsTT
  • NM_000551.3:c.330_331delCAinsTT
  • NR_176335.1:n.400_401delCAinsTT
Protein change:
S111C
Molecular consequence:
  • NM_000551.4:c.330_331delinsTT - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354723.2:c.330_331delinsTT - missense variant - [Sequence Ontology: SO:0001583]
  • NM_198156.3:c.330_331delinsTT - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Chuvash polycythemia
Synonyms:
POLYCYTHEMIA, VHL-DEPENDENT; Erythrocytosis, familial, 2
Identifiers:
MONDO: MONDO:0009892; MedGen: C1837915; Orphanet: 238557; OMIM: 263400
Name:
Von Hippel-Lindau syndrome (VHLS)
Synonyms:
VHL syndrome; Von Hippel-Lindau
Identifiers:
MONDO: MONDO:0008667; MedGen: C0019562; Orphanet: 892; OMIM: 193300

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003525091Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Oct 22, 2023)
germlineclinical testing

PubMed (10)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study.

Dollfus H, Massin P, Taupin P, Nemeth C, Amara S, Giraud S, Béroud C, Dureau P, Gaudric A, Landais P, Richard S.

Invest Ophthalmol Vis Sci. 2002 Sep;43(9):3067-74.

PubMed [citation]
PMID:
12202531

Hereditary phaeochromocytomas and paragangliomas: a study of five susceptibility genes.

Bauters C, Vantyghem MC, Leteurtre E, Odou MF, Mouton C, Porchet N, Wemeau JL, Proye C, Pigny P.

J Med Genet. 2003 Jun;40(6):e75. No abstract available.

PubMed [citation]
PMID:
12807974
PMCID:
PMC1735500
See all PubMed Citations (10)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003525091.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (10)

Description

This sequence change replaces serine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 111 of the VHL protein (p.Ser111Cys). Information on the frequency of this variant in the gnomAD database is not available, as this variant may be reported differently in the database. A different variant (c.331A>T) giving rise to the same protein effect has been determined to be pathogenic (PMID: 12202531, 12807974). This suggests that this variant is also likely to be causative of disease. This variant is also known as 543–544 CA→TT. ClinVar contains an entry for this variant (Variation ID: 2203305). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant disrupts the p.Ser111 amino acid residue in VHL. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 7728151, 9829911, 10761708, 14722919, 25562111, 25867206, 27527340). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024